Cocaine cue-induced dopamine release in the human prefrontal cortex

Journal of Psychiatry and Neuroscience

Volumn 41, Issue 5, 2016, Pages 322-330

  Milella, Michele S ^a   Fotros, Aryandokht ^b   Gravel, Paul ^c   Casey, Kevin F ^d   Larcher, Kevin ^e   Verhaeghe, Jeroen A J ^f   Cox, Sylvia M L ^a   Reader, Andrew J ^c,g   Dagher, Alain ^e   Benkelfat, Chawki ^e   Leyton, Marco ^e,h  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF ANTWERP   (Belgium)

^g ST THOMAS HOSPITAL   (United Kingdom)

^h and Applied Physiology   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; FALLYPRIDE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; BENZAMIDE DERIVATIVE; DOPAMINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE UPTAKE INHIBITOR; FALLYPRIDE; FLUORINE; FLUORINE-18;

ADULT; ANTERIOR CINGULATE; ARTICLE; CLINICAL ARTICLE; COCAINE DEPENDENCE; COCAINE SELECTIVE SEVERITY ASSESSMENT SCALE; CORPUS STRIATUM; DISEASE SEVERITY ASSESSMENT; DOPAMINE RELEASE; DORSOLATERAL PREFRONTAL CORTEX; DRUG BINDING; DSM-IV; FEMALE; HUMAN; MALE; MEDIAL ORBITOFRONTAL CORTEX; MESENCEPHALON; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; PERIKARYON; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; VISUAL ANALOG SCALE; WITHDRAWAL SYNDROME; ASSOCIATION; BRAIN MAPPING; CRAVING; DIAGNOSTIC IMAGING; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PSYCHOLOGY;

ADULT; BENZAMIDES; BRAIN MAPPING; COCAINE; COCAINE-RELATED DISORDERS; CORPUS STRIATUM; CRAVING; CUES; DOPAMINE; DOPAMINE D2 RECEPTOR ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; RADIOPHARMACEUTICALS;

EID: 84984856616     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.150207     Document Type: Article

References (68)

1. Miller EK. The prefrontal cortex: complex neural properties for complex behavior. Neuron 1999;22:15-7.
2. Rushworth MF, Behrens TE. Choice, uncertainty and value in pre-frontal and cingulate cortex. Nat Neurosci 2008;11:389-97.
3. Grant S, London ED, Newlin DB, et al. Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci U S A 1996;93:12040-5.
4. Childress AR, Mozley PD, McElgin W, et al. Limbic activation dur-ing cue-induced cocaine craving. Am J Psychiatry 1999;156:11-8.
5. Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci 2011;12:652-69.
6. Goldman-Rakic PS. Circuitry of the primate prefrontal cortex and the regulation of behavior by representational memory. In: Plum F, Mountcastle V, editors. Handbook of physiology. Bethesda (MD): American Physiology Society; 1997:373-416.
7. McFarland K, Kalivas PW. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 2001;21:8655-63.
8. Park WK, Bari AA, Jey AR, et al. Cocaine administered into the medial prefrontal cortex reinstates cocaine-seeking behavior by in-creasing AMPA receptor-mediated glutamate transmission in the nucleus accumbens. J Neurosci 2002;22:2916-25.
9. Olsen CM, Duvauchelle CL. Prefrontal cortex D1 modulation of the reinforcing properties of cocaine. Brain Res 2006;1075:229-35.
10. Bolla K, Ernst M, Kiehl K, et al. Prefrontal cortical dysfunction in ab-stinent cocaine abusers. J Neuropsychiatry Clin Neurosci 2004;16:456-64.
11. Volkow ND, Fowler JS, Wang GJ, et al. Dopamine in drug abuse and addiction: results from imaging studies and treatment impli-cations. Mol Psychiatry 2004;9:557-69.
12. Jasinska AJ, Stein EA, Kaiser J, et al. Factors modulating neural re-activity to drug cues in addiction: a survey of human neuroimaging studies. Neurosci Biobehav Rev 2014;38:1-16.
13. Riccardi P, Li R, Ansari MS, et al. Amphetamine-induced displace-ment of [18F] fallypride in striatum and extrastriatal regions in humans. Neuropsychopharmacology 2006;31:1016-26.
14. Cropley VL, Innis RB, Nathan PJ, et al. Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans. Synapse 2008;62:399-408.
15. Lataster J, Collip D, Ceccarini J, et al. Psychosocial stress is associ-ated with in vivo dopamine release in human ventromedial pre-frontal cortex: a positron emission tomography study using [(1)(8)F]fallypride. Neuroimage 2011;58:1081-9.
16. Lataster J, Collip D, Ceccarini J, et al. Familial liability to psychosis is associated with attenuated dopamine stress signaling in ventro-medial prefrontal cortex. Schizophr Bull 2014;40:66-77.
17. Nagano-Saito A, Dagher A, Booij L, et al. Stress-induced dopamine release in human medial prefrontal cortex-(18) F-Fallypride/PET study in healthy volunteers. Synapse 2013;67:821-30.
18. Vanderschuren LJ, Everitt BJ. Behavioral and neural mechanisms of compulsive drug seeking. Eur J Pharmacol 2005;526:77-88.
19. Volkow ND, Fowler JS, Wang GJ, et al. Imaging dopamine’s role in drug abuse and addiction. Neuropharmacology 2009;56(Suppl 1):3-8.
20. Kilts CD, Schweitzer JB, Quinn CK, et al. Neural activity related to drug craving in cocaine addiction. Arch Gen Psychiatry 2001;58:334-41.
21. Maas LC, Lukas SE, Kaufman MJ, et al. Functional magnetic resonance imaging of human brain activation during cue-induced co-caine craving. Am J Psychiatry 1998;155:124-6.
22. Lammel S, Hetzel A, Hackel O, et al. Unique properties of mesopre-frontal neurons within a dual mesocorticolimbic dopamine system. Neuron 2008;57:760-73.
23. Chiodo LA, Bannon MJ, Grace AA, et al. Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience 1984;12:1-16.
24. Piazza PV, Rougé-Pont F, Deminière JM, et al. Dopaminergic ac-tivity is reduced in the prefrontal cortex and increased in the nu-cleus accumbens of rats predisposed to develop amphetamine self- administration. Brain Res 1991;567:169-74.
25. Marinelli M, White FJ. Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of mid-brain dopamine neurons. J Neurosci 2000;20:8876-85.
26. Wolf ME, White FJ, Nassar R, et al. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J Pharmacol Exp Ther 1993;264:249-55.
27. Marinelli M, Cooper DC, Baker LK, et al. Impulse activity of mid-brain dopamine neurons modulates drug-seeking behavior. Psychopharmacology (Berl) 2003;168:84-98.
28. Buckholtz JW, Treadway MT, Cowan RL, et al. Dopaminergic net-work differences in human impulsivity. Science 2010;329:532.
29. Xue Y, Steketee JD, Rebec GV, et al. Activation of D2-like receptors in rat ventral tegmental area inhibits cocaine-reinstated drug-seeking behavior. Eur J Neurosci 2011;33:1291-8.
30. Fotros A, Casey KF, Larcher K, et al. Cocaine cue-induced dopamine release in amygdala and hippocampus: a high-resolution PET [18F]fallypride study in cocaine dependent participants. Neuropsychopharmacology 2013;38:1780-8.
31. Mukherjee J, Christian BT, Dunigan KA, et al. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging ef-fects on dopamine D-2/D-3 receptors. Synapse 2002;46:170-88.
32. Christian BT, Narayanan TK, Shi B, et al. Quantitation of striatal and extrastriatal D-2 dopamine receptors using PET imaging of [(18)F]fallypride in nonhuman primates. Synapse 2000;38:71-9.
33. Vernaleken I, Peters L, Raptis M, et al. The applicability of SRTM in [(18)F]fallypride PET investigations: impact of scan durations. J Cereb Blood Flow Metab 2011;31:1958-66.
34. Innis RB, Cunningham VJ, Delforge J, et al. Consensus nomencla-ture for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 2007;27:1533-9.
35. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage 1996;4:153-8.
36. Zhou Y, Endres CJ, Brasic JR, et al. Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model. Neuroimage 2003;18:975-89.
37. Hall H, Farde L, Halldin C, et al. Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride. Synapse 1996;23:115-23.
38. Vandehey NT, Moirano JM, Converse AK, et al. High-affinity do-pamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol. J Cereb Blood Flow Metab 2010;30:994-1007.
39. Wong DF, Kuwabara H, Schretlen DJ, et al. Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology 2006;31:2716-27.
40. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008;40:879-91.
41. Garavan H, Pankiewicz J, Bloom A, et al. Cue-induced cocaine crav-ing: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry 2000;157:1789-98.
42. Bassareo V, Di Chiara G. Differential influence of associative and nonassociative learning mechanisms on the responsiveness of pre-frontal and accumbal dopamine transmission to food stimuli in rats fed ad libitum. J Neurosci 1997;17:851-61.
43. St Onge JR, Ahn S, Phillips AG, et al. Dynamic fluctuations in dopa-mine efflux in the prefrontal cortex and nucleus accumbens during risk-based decision making. J Neurosci 2012;32:16880-91.
44. Feenstra MG, Botterblom MH. Rapid sampling of extracellular dopa-mine in the rat prefrontal cortex during food consumption, handling and exposure to novelty. Brain Res 1996;742:17-24.
45. Sorg BA, Kalivas PW. Effects of cocaine and footshock stress on ex-tracellular dopamine levels in the medial prefrontal cortex. Neuro-science 1993;53:695-703.
46. Chudasama Y, Robbins TW. Dopaminergic modulation of visual attention and working memory in the rodent prefrontal cortex. Neuropsychopharmacology 2004;29:1628-36.
47. Phillips AG, Vacca G, Ahn S. A top-down perspective on dopamine, motivation and memory. Pharmacol Biochem Behav 2008;90:236-49.
48. Hitchcott PK, Quinn JJ, Taylor JR. Bidirectional modulation of goal-directed actions by prefrontal cortical dopamine. Cereb Cortex 2007;17:2820-7.
49. Schoenbaum G, Roesch M. Orbitofrontal cortex, associative learn-ing, and expectancies. Neuron 2005;47:633-6.
50. Kahnt T, Park SQ, Haynes JD, et al. Disentangling neural represen-tations of value and salience in the human brain. Proc Natl Acad Sci U S A 2014;111:5000-5.
51. Kennerley SW, Walton ME, Behrens TE, et al. Optimal decision making and the anterior cingulate cortex. Nat Neurosci 2006;9:940-7.
52. Peters J, Pattij T, De Vries TJ. Targeting cocaine versus heroin memories: divergent roles within ventromedial prefrontal cortex. Trends Pharmacol Sci 2013;34:689-95.
53. Seeman P, Lee T. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 1975;188:1217-9.
54. Stamford JA, Kruk ZL, Millar J. Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data. Br J Pharmacol 1991;102:45-50.
55. Tournier BB, Steimer T, Millet P, et al. Innately low D2 receptor availability is associated with high novelty-seeking and enhanced behavioural sensitization to amphetamine. Int J Neuropsychopharmacol 2013;16:1819-34.
56. de Jong JW, Roelofs TJ, Mol FM, et al. Reducing ventral tegmental dopamine D2 receptor expression selectively boosts incentive mo-tivation. Neuropsychopharmacology 2015;40: 10.1038/npp.2015.60.
57. Volkow ND, Wang GJ, Telang F, et al. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 2006;26:6583-8.
58. Everitt BJ, Robbins TW. Drug addiction: updating actions to habits to compulsions ten years on. Annu Rev Psychol 2016;67:23-50.
59. Robinson TE, Berridge KC. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci 2008;363:3137-46.
60. Berridge KC, Kringelbach ML. Neuroscience of affect: brain mech-anisms of pleasure and displeasure. Curr Opin Neurobiol 2013;23:294-303.
61. Gu H, Salmeron BJ, Ross TJ, et al. Mesocorticolimbic circuits are impaired in chronic cocaine users as demonstrated by resting-state functional connectivity. Neuroimage 2010;53:593-601.
62. Sinha R, Li CS. Imaging stress- and cue-induced drug and alcohol craving: association with relapse and clinical implications. Drug Alcohol Rev 2007;26:25-31.
63. Narendran R, Frankle WG, Mason NS, et al. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride. Synapse 2009;63:447-61.
64. Slifstein M, Kegeles LS, Xu X, et al. Striatal and extrastriatal dopa-mine release measured with PET and [(18)F] fallypride. Synapse 2010;64:350-62.
65. Gründer G, Siessmeier T, Piel M, et al. Quantification of D2-like dopamine receptors in the human brain with [18F]desmethoxyfal-lypride. J Nucl Med 2003;44:109-16.
66. Pinborg LH, Videbaek C, Ziebell M, et al. [123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference region. Neuroimage 2007;34:1450-3.
67. Mukherjee J, Yang ZY, Brown T, et al. Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride. Nucl Med Biol 1999;26:519-27.
68. Slifstein M, Hwang DR, Huang Y, et al. In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates. Psychopharmacology (Berl) 2004;175:274-86.